Research Core (Amnis ImageStreamX Core)

研究核心(Amnis ImageStreamX 核心)

基本信息

  • 批准号:
    8444012
  • 负责人:
  • 金额:
    $ 9.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-17 至
  • 项目状态:
    未结题

项目摘要

We propose to establish a new Amnis ImageStreamX Core. Microscopy can image cytological rearrangements, cell:cell interactions, protein and membrane localization, and cell signaling events. However, such methods are neither high throughput nor quantitative. Nor are they adapted for real-time signaling or facile for the separation of defined cell types from mixtures. With these limitations in mind, Yale School of Medicine (YSM) acquired through a shared instrument grant an Amnis ImageStreamX. The Amnis ImageStreamX is a multispectral imaging instrument that acquires 12 channels of cellular imagery. By collecting large numbers of images per sample and providing numerical representation of image-based features, the ImageStreamX combines the per cell information content of standard microscopy with the statistical significance afforded by large sample sizes in standard flow cytometry. The best applications for the ImageStreamX take advantage of its abilities to locate and quantitate the distribution of signals on, within or between cells. This is the only such instrument at YSM. While there have been important discoveries made with the Amnis, the instrument is clearly underutilized. This is despite an enthusiastic initial response during a trial period wherein an expert from Amnis assisted in planning experiments, running samples and analyzing data on-site for 3 days. During this short time, preliminary data were obtained for 10 projects from 10 independent investigators. Whereas this early success was achieved with an expert on-site operator, the model applied for ongoing use of the Amnis was to treat as a user-operated 4-colorfiow cytometer. This model was not self-sustaining. Key aspects of the technology and in particular the required analysis of massive data sets rendered optimal use of the Amnis more complicated than a flow cytometer and therefore less accessible. This proposal seeks to remedy this by applying lessons learned by the P30 2P Core for which a dedicated and experienced operator participates in all phases of the work including experimental planning, training of users, imaging, assistance and training in data analysis. We propose to apply the same model to the Amnis so as to augment its impact on the study of rheumatic and immunological diseases, and the pathways that mediate their pathogenesis.
我们建议建立一个新的Amnis ImageStreamX核心。显微镜可以成像细胞学重排,细胞:细胞相互作用,蛋白质和膜定位,以及细胞信号事件。然而,这样的方法既不是高通量的,也不是定量的。它们也不适于实时信号传导或易于从混合物中分离确定的细胞类型。考虑到这些限制,耶鲁大学医学院(YSM)通过共享工具获得了Amnis ImageStreamX。Amnis ImageStreamX是一种多光谱成像仪器,可采集12个通道的细胞图像。通过收集每个样本的大量图像并提供基于图像的特征的数字表示,ImageStreamX将标准显微镜的每个细胞信息内容与标准流式细胞术中大样本量提供的统计学显著性相结合。ImageStreamX的最佳应用是利用其定位和定量细胞上、细胞内或细胞间信号分布的能力。这是YSM唯一的此类仪器。虽然Amnis有重要的发现,但该仪器显然没有得到充分利用。尽管在试验期间,来自Amnis的专家协助计划实验,运行样品和现场分析数据3天,但最初的反应很热烈。在这短短的时间内,从10名独立调查员那里获得了10个项目的初步数据。尽管这一早期成功是通过现场专家操作员实现的,但Amnis持续使用的模型是作为用户操作的4色流式细胞仪处理。这种模式不能自我维持。该技术的关键方面,特别是对大量数据集的必要分析,使得Amnis的最佳使用比流式细胞仪更复杂,因此更难获得。该提案旨在通过应用P30 2P核心的经验教训来弥补这一点,其中专门和经验丰富的操作员参与工作的所有阶段,包括实验规划,用户培训,成像,数据分析的援助和培训。我们建议将相同的模型应用于羊膜,以增加其对风湿性和免疫性疾病研究的影响,以及介导其发病机制的途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Warren D Shlomchik其他文献

A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRDsup+/sup AML or ALL or Poor/Very Poor Risk MDS
一项 1/1b 期多中心递增剂量研究,以评估 HA-1 次要组织相容性抗原反应性 TCR 修饰的 T 细胞(BSB-1001)在接受 HLA 匹配的同种异体造血干细胞移植(alloSCT)用于 MRD+AML 或 ALL 或不良/极差风险 MDS 患者中的安全性
  • DOI:
    10.1182/blood-2022-168949
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
    23.100
  • 作者:
    Sawa Ito;Christine Voigt;Constantinos Panousis;Tim Mayall;Mark Shlomchik;Jennifer Roy;Egidio Brocca Cofano;Stephanie Stras;David Apelian;Warren D Shlomchik
  • 通讯作者:
    Warren D Shlomchik
Pilot Trial of IFN-γ and Donor Lymphocyte Infusion to Treat Relapsed AML and MDS after Allogeneic Hematopoietic Stem Cell Transplantation
  • DOI:
    10.1182/blood-2022-157054
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Sawa Ito;Elizabeth F Krakow;Kedwin Ventura;Amy Rodger;Emily Geramita;Erika Moore;Geoffrey R Hill;Warren D Shlomchik
  • 通讯作者:
    Warren D Shlomchik
A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD<sup>+</sup> AML or ALL or Poor/Very Poor Risk MDS
  • DOI:
    10.1182/blood-2022-168949
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Sawa Ito;Christine Voigt;Constantinos Panousis;Tim Mayall;Mark Shlomchik;Jennifer Roy;Egidio Brocca Cofano;Stephanie Stras;David Apelian;Warren D Shlomchik
  • 通讯作者:
    Warren D Shlomchik

Warren D Shlomchik的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Warren D Shlomchik', 18)}}的其他基金

Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect
IFN-γ 使 AML 对移植物抗白血病效应敏感的机制
  • 批准号:
    10394937
  • 财政年份:
    2021
  • 资助金额:
    $ 9.97万
  • 项目类别:
Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect
IFN-γ 使 AML 对移植物抗白血病效应敏感的机制
  • 批准号:
    10609407
  • 财政年份:
    2021
  • 资助金额:
    $ 9.97万
  • 项目类别:
Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect
IFN-γ 使 AML 对移植物抗白血病效应敏感的机制
  • 批准号:
    10217590
  • 财政年份:
    2021
  • 资助金额:
    $ 9.97万
  • 项目类别:
Graft-versus-Host Disease: Local Maintenance in Target Tissues by Tissue Resident Memory-Type Cells.
移植物抗宿主病:组织驻留记忆型细胞对目标组织的局部维持。
  • 批准号:
    9756456
  • 财政年份:
    2018
  • 资助金额:
    $ 9.97万
  • 项目类别:
Graft-versus-Host Disease: Local Maintenance in Target Tissues by Tissue Resident Memory-Type Cells.
移植物抗宿主病:组织驻留记忆型细胞对目标组织的局部维持。
  • 批准号:
    10165801
  • 财政年份:
    2018
  • 资助金额:
    $ 9.97万
  • 项目类别:
GVL Resistance: Immune selection, T cell ignorance and T cell exhaustion
GVL 抵抗:免疫选择、T 细胞无知和 T 细胞耗竭
  • 批准号:
    8675278
  • 财政年份:
    2013
  • 资助金额:
    $ 9.97万
  • 项目类别:
GVL Resistance: Immune selection, T cell ignorance and T cell exhaustion
GVL 抵抗:免疫选择、T 细胞无知和 T 细胞耗竭
  • 批准号:
    8477401
  • 财政年份:
    2013
  • 资助金额:
    $ 9.97万
  • 项目类别:
GVL Resistance: Immune selection, T cell ignorance and T cell exhaustion
GVL 抵抗:免疫选择、T 细胞无知和 T 细胞耗竭
  • 批准号:
    9039753
  • 财政年份:
    2013
  • 资助金额:
    $ 9.97万
  • 项目类别:
Dendritic Cell Subsets and Paths of Maturation in GVHD
GVHD 中的树突状细胞亚群和成熟途径
  • 批准号:
    8117703
  • 财政年份:
    2010
  • 资助金额:
    $ 9.97万
  • 项目类别:
Research Core (Amnis ImageStreamX Core)
研究核心(Amnis ImageStreamX 核心)
  • 批准号:
    8725465
  • 财政年份:
    2007
  • 资助金额:
    $ 9.97万
  • 项目类别:

相似海外基金

Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
  • 批准号:
    502578
  • 财政年份:
    2024
  • 资助金额:
    $ 9.97万
  • 项目类别:
B cell development, autoimmunity and immune regulation
B 细胞发育、自身免疫和免疫调节
  • 批准号:
    MR/Y033701/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.97万
  • 项目类别:
    Research Grant
Applying advanced understanding of CTLA-4 function to optimise therapies for autoimmunity
应用对 CTLA-4 功能的深入理解来优化自身免疫疗法
  • 批准号:
    MR/Y001273/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.97万
  • 项目类别:
    Research Grant
MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
MUC16 (CA125) 突变促进系统性硬化症的纤维化和自身免疫
  • 批准号:
    478933
  • 财政年份:
    2023
  • 资助金额:
    $ 9.97万
  • 项目类别:
    Operating Grants
Development of serologic test for early risk stratification of islet autoimmunity in genetically predisposed T1D individuals
开发用于遗传易感性 T1D 个体胰岛自身免疫早期风险分层的血清学检测
  • 批准号:
    10760885
  • 财政年份:
    2023
  • 资助金额:
    $ 9.97万
  • 项目类别:
Mechanisms of New-Onset Autoimmunity/Longitudinal Immune Systems Analysis (MONA-LISA)
新发自身免疫/纵向免疫系统分析(MONA-LISA)的机制
  • 批准号:
    10655219
  • 财政年份:
    2023
  • 资助金额:
    $ 9.97万
  • 项目类别:
Autoimmunity-Associated B Cells in Lupus Nephritis
狼疮性肾炎中自身免疫相关的 B 细胞
  • 批准号:
    10582053
  • 财政年份:
    2023
  • 资助金额:
    $ 9.97万
  • 项目类别:
Heparan sulfate as a platform to boost regulatory T cell suppression of autoimmunity
硫酸乙酰肝素作为增强调节性 T 细胞抑制自身免疫的平台
  • 批准号:
    490663
  • 财政年份:
    2023
  • 资助金额:
    $ 9.97万
  • 项目类别:
    Operating Grants
The interplay of sex hormones and chromosomes dictates pathogenicity in progressive CNS autoimmunity.
性激素和染色体的相互作用决定了进行性中枢神经系统自身免疫的致病性。
  • 批准号:
    488982
  • 财政年份:
    2023
  • 资助金额:
    $ 9.97万
  • 项目类别:
    Operating Grants
Understanding autoimmunity: Why do B cells sometimes attack our tissues instead of protecting us from infections?
了解自身免疫:为什么 B 细胞有时会攻击我们的组织而不是保护我们免受感染?
  • 批准号:
    2889164
  • 财政年份:
    2023
  • 资助金额:
    $ 9.97万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了